European Journal of Cancer Supplements (EJCS)

European Journal of Cancer Supplements (often abbreviated Eur. J. Cancer Suppl.) is an open access companion journal to the European Journal of Cancer, published by Elsevier. It focuses on oncology and cancer research, serving as a supplementary outlet for topics that complement the main journal’s scope, including preclinical and basic cancer research, translational oncology, clinical oncology, and cancer epidemiology and prevention. As an open access publication, all articles are published immediately upon acceptance and are available freely to readers worldwide. This journal is designed to host thematically structured collections of work, often relating to conference symposia, invited article collections, and commissioned supplements in cancer science and clinical practice. It supports dissemination of research that may be broad, specialized, or focused on emerging areas within the oncology community. Authors considering publication should discuss proposals with the editorial office. The journal is associated with major European cancer organizations such as the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA), reflecting its role in advancing collaborative and high‑impact cancer research across Europe and globally.

European Journal of Cancer Supplements (EJCS) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer Research, Oncology, preclinical and basic cancer research, translational oncology, clinical oncology, cancer epidemiology and prevention , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1359-6349, E-ISSN: 1878-1217, Established: 2003,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE